FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

14233411000001106: Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50617301000001114 Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50617401000001118 Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Is a Generic Femoston 2/10mg tablets 84 tablet true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Is pack of Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has active ingredient Estrogen false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has AMP Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start